-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Guardant Health, Raises Price Target to $210

Benzinga·07/31/2026 16:06:43
语音播报
TD Cowen analyst Dan Brennan maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $200 to $210.